124 related articles for article (PubMed ID: 18069641)
1. [Gefitinib in the treatment of male patients with advanced non-small-cell lung cancer].
Wang B; Zhang XR; Chu DT
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):549-51. PubMed ID: 18069641
[TBL] [Abstract][Full Text] [Related]
2. [IRESSA in the treatment of advanced non-small-cell lung cancer patients who failed to respond previous chemotherapy].
Wang B; Zhang XR; Chu DT
Zhonghua Zhong Liu Za Zhi; 2004 Dec; 26(12):742-5. PubMed ID: 15733394
[TBL] [Abstract][Full Text] [Related]
3. [Gefitinib in the treatment of refractory non-small cell lung cancer].
Xu JF; Zhou CC; Li AW
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):938-40. PubMed ID: 18478936
[TBL] [Abstract][Full Text] [Related]
4. [Gefitinib in the treatment of advanced non-small cell lung cancer].
Yang L; Liu XY; Fang J; An TT; Wu MN
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):474-7. PubMed ID: 17152500
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)].
Huang H; Zhang Y; Zhao HY; Wang ZQ; Xu F; Xu GC; Zhang L; Guan ZZ
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):148-51. PubMed ID: 19538895
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of gefitinib on Chinese patients with locally advanced or metastatic non-small cell lung cancer: a clinical trial].
Guan ZZ; Zhang L; Li LY; Jiang GL; Liu XY; Chu DT; Zhao HY; Li W
Ai Zheng; 2005 Aug; 24(8):980-4. PubMed ID: 16086877
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy of gefitinib on advanced non-small cell lung cancer in expanded access program (EAP)].
Zhang Y; Zhang L; Xu F; Wang ZQ; Zhao HY; Guan ZZ; Xu GC; Pan ZK
Ai Zheng; 2006 Dec; 25(12):1561-4. PubMed ID: 17166387
[TBL] [Abstract][Full Text] [Related]
8. [Gefitinib in the treatment of advanced non-small cell lung cancer with brain metastasis].
Wu C; Li LY; Wang MZ; Zhang L; Zhang XT; Zhong W; Wang SL; Wang HZ
Zhonghua Zhong Liu Za Zhi; 2007 Dec; 29(12):943-5. PubMed ID: 18478938
[TBL] [Abstract][Full Text] [Related]
9. [Gefitinib in the treatment of advanced non-small-cell lung cancer].
Zhang L; Yu SY
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):539-41. PubMed ID: 17147123
[TBL] [Abstract][Full Text] [Related]
10. [Clinical observation of gefitinib for the treatment of 125 cases with advanced non-small cell lung cancer].
Gu AQ; Wang HM; Shi CL; Xiong LW; Gao ZQ; Han BH
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):71-4. PubMed ID: 20211075
[TBL] [Abstract][Full Text] [Related]
11. [Erlotinib in the treatment of advanced non-small-cell lung cancer (NSCLC)].
Tang CH; Liu XQ; Gao HJ; Li JJ; Guo WF; Li XY; Wang WX; Liu B; Qu LL; Wang WW
Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):143-7. PubMed ID: 20403247
[TBL] [Abstract][Full Text] [Related]
12. Skin rash and bronchoalveolar histology correlates with clinical benefit in patients treated with gefitinib as a therapy for previously treated advanced or metastatic non-small cell lung cancer.
Dudek AZ; Kmak KL; Koopmeiners J; Keshtgarpour M
Lung Cancer; 2006 Jan; 51(1):89-96. PubMed ID: 16290256
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, "Iressa") on an expanded access study.
Jänne PA; Gurubhagavatula S; Yeap BY; Lucca J; Ostler P; Skarin AT; Fidias P; Lynch TJ; Johnson BE
Lung Cancer; 2004 May; 44(2):221-30. PubMed ID: 15084387
[TBL] [Abstract][Full Text] [Related]
14. [Safety and efficacy of gefitinib for treatment of advanced non-small cell lung cancer].
Xu JM; Li YM; Liu XQ; Zhang Y; Han Y; Yang WW; Song ST
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):66-9. PubMed ID: 17575699
[TBL] [Abstract][Full Text] [Related]
15. Effect of gefitinib challenge to initial treatment with non-small cell lung cancer.
Chen X; Li W; Hu X; Geng Y; Wang R; Yin Y; Shu Y
Biomed Pharmacother; 2011 Dec; 65(8):542-6. PubMed ID: 21840160
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of non-small cell lung cancer with gefitinib].
Zhang XT; Li LY; Wang SL; Mu XL; Wang MZ
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Mar; 28(3):180-3. PubMed ID: 15854414
[TBL] [Abstract][Full Text] [Related]
17. Activity of a specific inhibitor, gefitinib (Iressa, ZD1839), of epidermal growth factor receptor in refractory non-small-cell lung cancer.
Santoro A; Cavina R; Latteri F; Zucali PA; Ginanni V; Campagnoli E; Ferrari B; Morenghi E; Pedicini V; Roncalli M; Alloisio M; Ravasi G; Soto Parra HJ
Ann Oncol; 2004 Jan; 15(1):33-7. PubMed ID: 14679116
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of erlotinib for acquired resistance to gefitinib in patients with advanced non-small cell lung cancer.
Horiike A; Yamamoto N; Tanaka H; Yanagitani N; Kudo K; Ohyanagi F; Ono A; Naito T; Murakami H; Horai T; Nishio M
Anticancer Res; 2014 Apr; 34(4):1975-81. PubMed ID: 24692734
[TBL] [Abstract][Full Text] [Related]
19. [Clinical observation of icotinib hydrochloride for patients with advanced non-small cell lung cancer].
Li X; Yang XJ; Sun YF; Qin N; Lü JL; Wu YH; Zhang H; Zhang Q; Zhang SC
Zhonghua Zhong Liu Za Zhi; 2012 Aug; 34(8):627-31. PubMed ID: 23159001
[TBL] [Abstract][Full Text] [Related]
20. Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancer.
Argiris A; Mittal N
Lung Cancer; 2004 Mar; 43(3):317-22. PubMed ID: 15165090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]